The U.S. Oncology business is preparing for the potential U.S. launch of an mRNA-based individualized neoantigen therapy for early-stage melanoma, developed through an alliance partnership. The Associate Director will serve as the commercial lead responsible for designing, integrating, and continuously improving the operational processes that enable delivery of the Intismeran treatment journey. Reporting to the Director, Individualized Therapy Operations, this role is the primary commercial representative across cross-functional operational teams and external partners. It will align workflows, governance, stakeholder activities, and supporting technologies across treatment sites, pathology laboratories, sequencing providers, manufacturing partners, distributors, alliance stakeholders, and internal teams. The role will establish an integrated, scalable, and reliable operating model, remove operational barriers, improve customer and treatment site experiences, and support treatment completion and future scalability.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director